Tetramethylpyrazine protects retinal capillary endothelial cells (TR-iBRB2) against IL-1β-induced nitrative/oxidative stress

International Journal of Molecular Sciences

Volumn 16, Issue 9, 2015, Pages 21775-21790

  Zhu, Xue ^a   Wang, Ke ^a   Zhang, Kai ^a   Tan, Xuhua ^b   Wu, Zhifeng ^b   Sun, Song ^b   Zhou, Fanfan ^c   Zhu, Ling ^d  

^a BEIJING HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Nitrosative stress; Oxidative stress; Tetramethylpyrazine; TR iBRB2 cells

Indexed keywords

CYTOCHROME C; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TETRAMETHYLPYRAZINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC ACID DERIVATIVE; PROTECTIVE AGENT; PYRAZINE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC RETINOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLOW CYTOMETRY; LEUKOCYTE ADHERENCE; LEUKOSTASIS; MALE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD RETINA BARRIER; CELL ADHESION; CELL LINE; CELL NUCLEUS; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LEUKOCYTE; METABOLISM; MITOCHONDRION; PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; APOPTOSIS; BLOOD-RETINAL BARRIER; CELL ADHESION; CELL LINE; CELL NUCLEUS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; LEUKOCYTES; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PHOSPHORYLATION; PROTECTIVE AGENTS; PROTEIN TRANSPORT; PYRAZINES; RATS; REACTIVE OXYGEN SPECIES;

EID: 84941241875     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160921775     Document Type: Article

References (36)

1. Cunha-Vaz, J.; de Abreu, J.R.F.; Campos, A.J. Early breakdown of the blood-retinal barrier in diabetes. Br. J. Ophthalmol. 1975, 59, 649–656.
2. Hafezi-Moghadam, A. Mechanisms of blood-retinal barrier breakdown in diabetic retinopathy. In Visual Dysfunction in Diabetes, 2nd ed.; Tombran-Tink, J., Barnstable, C.J., et al., Eds.; Springer: New York, NY, USA, 2012; pp. 105–122.
3. Klaassen, I.; van Noorden, C.J.F.; Schlingemann, R.O. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog. Retin. Eye Res. 2013, 34, 19–48.
4. Huang, H.; Gandhi, J.K.; Zhong, X.; Wei, Y.; Gong, J.; Duh, E.J.; Vinores, S.A. TNFα is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Investig. Ophthalmol. Vis. Sci. 2011, 52, 1336–1344.
5. Kowluru, R.A.; Odenbach, S. Role of interleukin-1β in the pathogenesis of diabetic retinopathy. Br. J. Ophthalmol. 2004, 88, 1343–1347.
6. Qian, W.; Xiong, X.; Fang, Z.; Lu, H.; Wang, Z. Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury. Evid. Based Complement. Altern. Med. 2014, 2014, doi:10.1155/2014/107501.
7. Kao, T.K.; Chang, C.Y.; Ou, Y.C.; Chen, W.Y.; Kuan, Y.H.; Pan, H.C.; Liao, S.L.; Li, G.Z.; Chen, C.J. Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp. Neurol. 2013, 247, 188–201.
8. Chen, K.J.; Chen, K. Ischemic stroke treated with Ligusticum chuanxiong. Chin. Med. J. 1992, 105, 870–873.
9. Gong, X.; Ivanov, V.N.; Davidson, M.M.; Hei, T.K. Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death. Arch. Toxicol. 2015, 89, 1057–1070.
10. Liang, X.; Zhou, H.; Ding, Y.; Li, J.; Yang, C.; Luo, Y.; Li, S.; Sun, G.; Liao, X.; Min, W. TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model. Investig. Ophthalmol. Vis. Sci. 2012, 53, 2157-2169.
11. Yang, Z.; Zhang, Q.; Ge, J.; Tan, Z. Protective effects of tetramethylpyrazine on rat retinal cell cultures. Neurochem. Int. 2008, 52, 1176–1187.
12. Ou, Y.; Dong, X.; Liu, X.Y.; Cheng, X.C.; Cheng, Y.N.; Yu, L.G.; Guo, X.L. Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells. Biol. Pharm. Bull. 2010, 33, 432–438.
13. Yang, J.N.; Chen, J.M.; Luo, L.; Lin, S.C.; Li, D.; Hu, S.X. Tetramethylpyrazine protected photoreceptor cells of rats by modulating nuclear translocation of NF-κB. Acta Pharmacol. Sin. 2005, 26, 887–892.
14. Hosoya, K.I.; Tomi, M.; Ohtsuki, S.; Takanaga, H.; Ueda, M.; Yanai, N.; Obinata, M.; Terasaki, T. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp. Eye Res. 2001, 72, 163–172.
15. Zheng, L.; Kern, T.S. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front. Biosci. 2009, 14, 3974–3987.
16. El-Remessy, A.B.; Behzadian, M.A.; Abou-Mohamed, G.; Franklin, T.; Caldwell, R.W.; Caldwell, R.B. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 2003, 162, 1995–2004.
17. Joussen, A.M.; Poulaki, V.; Qin, W.; Kirchhof, B.; Mitsiades, N.; Wiegand, S.J.; Rudge, J.; Yancopoulos, G.D.; Adamis, A. P. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 2002, 160, 501–509.
18. Sinha, K.; Das, J.; Pal, P.; Sil, P. Oxidative stress: The mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch. Toxicol. 2013, 87, 1157–1180.
19. Caroppi, P.; Sinibaldi, F.; Fiorucci, L.; Santucci, R. Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein. Curr. Med. Chem. 2009, 16, 4058–4065.
20. Son, Y.; Kim, S.; Chung, H.T.; Pae, H.O. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 2013, 528, 27–48.
21. Zheng, Z.; Li, Z.; Chen, S.; Pan, J.; Ma, X. Tetramethylpyrazine attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways. Exp. Cell Res. 2013, 319, 2145–2151.
22. Wu, H.J.; Hao, J.; Wang, S.Q.; Jin, B.L.; Chen, X.B. Protective effects of ligustrazine on TNF-α-induced endothelial dysfunction. Eur. J. Pharmacol. 2012, 674, 365–369.
23. Leal, E.C.; Manivannan, A.; Hosoya, K.; Terasaki, T.; Cunha-Vaz, J.; Ambrosio, A. F.; Forrester, J.V. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2007, 48, 5257–5265.
24. Sahnoun, Z.; Jamoussi, K.; Zeghal, K.M. Free radicals and antioxidants: Physiology, human pathology and therapeutic aspects (part II). Therapie 1998, 53, 315–339.
25. Rajan, S.; Ye, J.; Bai, S.; Huang, F.; Guo, Y.L. NF-κB, but not p38 MAP kinase, is required for TNF-α-induced expression of cell adhesion molecules in endothelial cells. J. Cell. Biochem. 2008, 105, 477–486.
26. Leal, E.C.; Martins, J.; Voabil, P.; Liberal, J.; Chiavaroli, C.; Bauer, J.; Cunha-Vaz, J.; Ambrosio, A.F. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010, 59, 2637–2645.
27. Kowluru, R.A.; Chan, P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, 2007, doi:10.1155/2007/43603.
28. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, 1005–1028.
29. Davis, W.; Ronai, Z.E.; Tew, K.D. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J. Pharmacol. Exp. Ther. 2001, 296, 1–6.
30. Anuradha, C.D.; Kanno, S.; Hirano, S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radic. Biol. Med. 2001, 31, 367–373.
31. Pan, J.S.; Hong, M.Z.; Ren, J.L. Reactive oxygen species: A double-edged sword in oncogenesis. World J. Gastroenterol. 2009, 15, 1702–1707.
32. Johnson, G.L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911–1912.
33. Gerhardinger, C.; Dagher, Z.; Sebastiani, P.; Park, Y.S.; Lorenzi, M. The transforming growth factor-β pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes 2009, 58, 1659–1667.
34. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254.
35. Lu, H.F.; Sue, C.C.; Yu, C.S.; Chen, S.C.; Chen, G.W.; Chung, J. G. Diallyl disulfide (DADS) induced apoptosis undergo caspase-3 activity in human bladder cancer T24 cells. Food Chem. Toxicol. 2004, 42, 1543–1552.
36. Yang, J.; Liu, X.; Bhalla, K.; Kim, C.N.; Ibrado, A.M.; Cai, J.; Peng, T.I.; Jones, D.P.; Wang, X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997, 275, 1129–1132.